Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report
نویسندگان
چکیده
DOI: 10.4103/2229-5178.209617 and Analysis of 38 Cases. Dermatol Surg 2015;41:1411‐8. 3. Tong LX, Weinstock M, Drews R, Sheikine Y, Kim CC. Widely metastatic squamous cell carcinoma originating from malignant transformation of hypertrophic lichen planus in a 24‐year‐old woman: Case report and review of the literature. Pediatr Dermatol 2015;32:e98‐101. 4. Wörheide J, Bonsmann G, Kolde G, Hamm H. Squamous epithelial carcinoma at the site of lichen ruber hypertrophicus of the glans penis. Hautarzt 1991;42:112‐5. 5. Joshi R, Durve U. Squamous cell carcinoma in hypertrophic lichen planus. Indian J Dermatol Venereol Leprol 2007;73:54‐5. 6. Krasowska D, Bogaczewicz J, Chodorowska G. Development of squamous cell carcinoma within lesions of cutaneous lichen planus. Eur J Dermatol 2007;17:447‐8. 7. Speziali L, Pusiol T, Zorzi MG, Morichetti D, Zumiani G. Pseudoepitheliomatous hyperplasia arising from hypertrophic lichen planus mimicking squamous cell carcinoma. G Ital Dermatol Venereol 2011;146:310‐1. 8. Pusiol T, Zorzi MG, Morichetti D, Speziali L. Pseudoepitheliomatous hyperplasia arising from hypertrophic lichen planus mimicking squamous cell carcinoma: Limited value of immunohistochemistry. Acta Dermatovenerol Croat 2012;20:112‐4.
منابع مشابه
Psoriasis: An Unusual Autoimmune Manifestation in a Boy with Common Variable Immunodeficiency
© 2017 Journal of Pediatric Neurosciences | Published by Wolters Kluwer Medknow This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. In conclu...
متن کاملLate Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan
PML caused by John Cunningham (JC) virus is a rare but an increasingly recognized entity. With the advent of newer immunomodulatory therapies with monoclonal antibodies, there is an increasing incidence of PML. Initially concern was restricted to patients treated for multiple sclerosis with natalizumab but more case reports are being reported during treatment for other conditions like Crohn's d...
متن کاملAn unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review
OBJECTIVES Primary hepatic lymphoma is an uncommon cause of hepatic space-occupying lesions. METHODS We describe the case of a 73-year-old man with primary hepatic lymphoma, who presented with a low-grade fever and lower limb weakness which had progressed in the past 2 months. RESULTS Abdominal ultrasound and computed tomography showed multiple small hepatic tumors. Echo-guided biopsy of th...
متن کاملEfficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Introduction Primary cold agglutinin disease (CAD) is a haemolytic anaemia caused by high titres of cold antibodies, usually IgM, directed against red blood cells1,2. Cold agglutinins are present at low titres in all normal individuals, but at high concentrations, the agglutinins can have pathological consequences. In the cool peripheral circulation, cold agglutinin-coated red blood cells activ...
متن کاملEnhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma
Obinutuzumab (GA101) is a novel glycoengineered type II CD20 antibody in development for non-Hodgkin lymphoma. We compared the anti-tumor activity of obinutuzumab and rituximab in preclinical studies using subcutaneous Z138 and WSU-DLCL2 xenograft mouse models. Obinutuzumab and rituximab were assessed alone and in combination with bendamustine, fludarabine, chlorambucil, doxorubicin and cycloph...
متن کامل